Form 990 for tax year 2022
Filed by THE ALBERT B SABIN VACCINE INSTITUTE INC.
Totals
- Total revenue
- $33,545,403
- Total expenses
- $31,282,727
- Contributions and grants received
- $33,467,236
- Grants paid
- $3,127,948
- Program service revenue
- $0
- Investment income
- $78,167
- Other revenue
- $0
- Total assets, end of year
- $21,704,675
- Total liabilities, end of year
- $7,350,391
- Net assets or fund balances, end of year
- $14,354,284
- Program services expenses (Part IX)
- $28,218,465
- Management and general expenses
- $2,705,937
- Fundraising expenses
- $358,325
- Program service expenses (Part III)
- $28,218,465
Program services were 90.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1e · Government grants (contributions)
$21,463,101
-
1f · All other contributions, gifts and grants
$12,004,135
-
3 · Investment income
total $64,893 · excluded $64,893
-
7a · Gross sales of assets other than inventory
securities $199,280
-
7b · Less cost or other basis and sales expenses
securities $186,006
-
7c · Gain or loss
securities $13,274
-
7d · Net gain or loss
total $13,274 · excluded $13,274
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $1,073,909 · program services $1,073,909
-
3 · Grants to foreign organizations and individuals
total $2,054,039 · program services $2,054,039
-
5 · Compensation of officers, directors and key employees
total $882,890 · program services $724,369 · management and general $125,967 · fundraising $32,554
-
7 · Other salaries and wages
total $5,710,335 · program services $4,790,986 · management and general $705,887 · fundraising $213,462
-
8 · Pension plan contributions
total $77,579 · program services $44,537 · management and general $30,706 · fundraising $2,336
-
9 · Other employee benefits
total $661,020 · program services $379,488 · management and general $261,636 · fundraising $19,896
-
10 · Payroll taxes
total $451,442 · program services $264,858 · management and general $170,036 · fundraising $16,548
-
11b · Fees: legal
total $132,811 · program services $124,811 · management and general $8,000
-
11c · Fees: accounting
total $21,708 · management and general $21,708
-
11g · Fees: other
total $17,317,875 · program services $16,702,901 · management and general $547,357 · fundraising $67,617
-
12 · Advertising and promotion
total $467,388 · program services $440,304 · management and general $24,279 · fundraising $2,805
-
13 · Office expenses
total $102,913 · program services $38,696 · management and general $64,046 · fundraising $171
-
14 · Information technology
total $84,088 · program services $34,201 · management and general $49,172 · fundraising $715
-
16 · Occupancy
total $268,707 · management and general $268,707
-
17 · Travel
total $550,586 · program services $492,322 · management and general $58,254 · fundraising $10
-
19 · Conferences, conventions and meetings
total $543,859 · program services $528,069 · management and general $15,790
-
22 · Depreciation, depletion and amortization
total $399,187 · program services $252,600 · management and general $146,587
-
23 · Insurance
total $241,223 · program services $195,456 · management and general $45,767
-
24a · Other expenses: Dues/subscriptions
total $129,540 · program services $62,738 · management and general $65,020 · fundraising $1,782
-
24b · Other expenses: Recruitment
total $61,548 · program services $3,965 · management and general $57,478 · fundraising $105
-
24c · Other expenses: Miscellaneous
total $47,768 · program services $7,904 · management and general $39,540 · fundraising $324
-
24d · Other expenses: Books & publications
total $2,312 · program services $2,312
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $2,243,106 · end of year $1,506,086
-
2 · Savings and temporary cash investments
beginning of year $8,663,012 · end of year $7,361,995
-
3 · Pledges and grants receivable
beginning of year $4,847,484 · end of year $9,587,532
-
4 · Accounts receivable
beginning of year $4,154 · end of year $89,556
-
9 · Prepaid expenses and deferred charges
beginning of year $310,497 · end of year $506,438
-
10a · Land, buildings and equipment: cost or other basis
$1,721,954
-
10b · Land, buildings and equipment: accumulated depreciation
$991,387
-
10c · Land, buildings and equipment, net
beginning of year $700,796 · end of year $730,567
-
11 · Investments: publicly traded securities
beginning of year $514,448 · end of year $444,763
-
14 · Intangible assets
beginning of year $1,454,553 · end of year $1,201,953
-
15 · Other assets
beginning of year $0 · end of year $275,785
-
17 · Accounts payable and accrued expenses
beginning of year $4,708,737 · end of year $5,814,295
-
25 · Other liabilities
beginning of year $1,810,112 · end of year $1,536,096
-
27 · Net assets without donor restrictions
beginning of year $2,745,224 · end of year $4,311,941
-
28 · Net assets with donor restrictions
beginning of year $9,473,977 · end of year $10,042,343
Mission and programs · 2022
Mission
To make vaccines more accessible, enable innovation and expand immunization across the globe.
Activities or mission (Part I)
To make vaccines more accessible, enable innovation and expand immunization.
-
Vaccine Research & DevelopmentThe Sabin Vaccine Institute supports innovative technologies and approaches in vaccine research and development to combat infectious and emerging threats to global health. Sabin's Research & Development strategy is to prioritize strong vaccine candidates that lack commercial value, targeting diseases that impact the world's most vulnerable populations. Sabin leverages the expertise of partners in the academic, public, and private sectors, and promotes open-source research.Ebola has taken the lives of nearly 14,000 people during the last decade. To protect communities across the globe from the critical threat posed by Ebola and the closely related, but lesser known, Marburg virus, Sabin is currently developing vaccines for Sudan ebolavirus and Marburg virus diseases based on technology licensed from GSK. The prophylactic vaccine candidates are based on GSK's proprietary ChAd3 platform. In 2019, the U.S. Health and Human Services' Biomedical Advanced Research and Development Authority awarded Sabin a multi-year development contract to advance development of the Marburg and Sudan ebolavirus vaccines
Expenses $16,826,411
-
Global ImmunizationDespite scientific advances and international support, 1.5 million people still die each year from diseases that could have been prevented by immunization. Sabin's Global Immunization arm focuses on improving vaccine distribution, increasing uptake, and driving more equitable access to vaccination services. Sabin works on these goals with a multi-layered programmatic approach including: advancing research to understand the social and behavioral drivers for vaccine acceptance and demand; fostering peer to peer collaboration on immunization and building capacity and leadership skills for immunization professionals; coalescing multi-sectoral partners and community leaders and influencers to support the introduction and expansion of new and under-utilized vaccines such as the HPV vaccine; and generating essential epidemiological data to inform immunization policy and implementation decisions for diseases such as typhoid.
Expenses $11,392,054 · Grants $3,127,948
As filed on the 2022 return. The filer continues this part on Schedule O, which is not shown here.
Listed in Part VII
-
Adegbola Richard
Trustee
- Total calculated
- $0
- Hours/week
- 2
-
Baylor Norman
Trustee
- Total calculated
- $0
- Hours/week
- 2
-
Commins Holman Wendy
Trustee
- Total calculated
- $0
- Hours/week
- 2
-
Djibo Yacine
Trustee
- Total calculated
- $0
- Hours/week
- 2
-
Fox Elizabeth
Trustee
- Total calculated
- $0
- Hours/week
- 2
-
Hoos Axel
Trustee
- Total calculated
- $0
- Hours/week
- 2
-
Libson Jeffrey
Trustee, Secretary
- Total calculated
- $0
- Hours/week
- 2
-
Omer Saad
Trustee
- Total calculated
- $0
- Hours/week
- 2
-
Rabinovich Regina
Trustee, Chair
- Total calculated
- $0
- Hours/week
- 2
-
Salisbury David
Trustee
- Total calculated
- $0
- Hours/week
- 2
-
Shea Jacqueline
Trustee
- Total calculated
- $0
- Hours/week
- 2
-
Suzich JoAnn
Trustee
- Total calculated
- $0
- Hours/week
- 2
-
Thoren Peter
Trustee,Vice Chair,Treasurer
- Total calculated
- $0
- Hours/week
- 2
-
Finan Amy
CEO
- Total calculated
- $469,182
- From this org
- $440,130
- From related orgs
- $0
- Other
- $29,052
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $387,395
- Bonus
- $50,000
- Other
- $2,735
- Deferred
- $10,141
- Nontaxable benefits
- $18,911
- Filer's total
- $469,182
-
DeLeon Kiju
CFO
- Total calculated
- $232,714
- From this org
- $214,044
- From related orgs
- $0
- Other
- $18,670
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $211,986
- Bonus
- $0
- Other
- $2,058
- Deferred
- $6,786
- Nontaxable benefits
- $11,884
- Filer's total
- $232,714
-
Davis Brian
CFO
- Total calculated
- $180,993
- From this org
- $166,891
- From related orgs
- $0
- Other
- $14,102
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $116,616
- Bonus
- $50,000
- Other
- $275
- Deferred
- $3,883
- Nontaxable benefits
- $10,219
- Filer's total
- $180,993
-
Garrett Denise
VP, Applied Epidemiology
- Total calculated
- $286,967
- From this org
- $258,426
- From related orgs
- $0
- Other
- $28,541
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $248,456
- Bonus
- $7,000
- Other
- $2,970
- Deferred
- $10,354
- Nontaxable benefits
- $18,187
- Filer's total
- $286,967
-
Knobler Stacey
VP,Vaccine Innovation & Global Immunization
- Total calculated
- $277,902
- From this org
- $255,479
- From related orgs
- $0
- Other
- $22,423
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $225,578
- Bonus
- $28,000
- Other
- $1,901
- Deferred
- $9,241
- Nontaxable benefits
- $13,182
- Filer's total
- $277,902
-
King Thomas
VP, Nonclinical
- Total calculated
- $283,563
- From this org
- $244,789
- From related orgs
- $0
- Other
- $38,774
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $242,947
- Bonus
- $0
- Other
- $1,842
- Deferred
- $10,417
- Nontaxable benefits
- $28,357
- Filer's total
- $283,563
-
Vert-Wong Ekaterina
VP, Portfolio & Alliance Management
- Total calculated
- $278,869
- From this org
- $244,347
- From related orgs
- $0
- Other
- $34,522
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $242,553
- Bonus
- $0
- Other
- $1,794
- Deferred
- $9,583
- Nontaxable benefits
- $24,939
- Filer's total
- $278,869
-
Williams Michelle
VP, Operations and HR
- Total calculated
- $264,557
- From this org
- $241,435
- From related orgs
- $0
- Other
- $23,122
- Hours/week
- 40
Schedule J breakdown matched by us
- Base
- $226,513
- Bonus
- $13,000
- Other
- $1,922
- Deferred
- $9,173
- Nontaxable benefits
- $13,949
- Filer's total
- $264,557
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those. A Schedule J breakdown is as filed: base pay, bonus, other, deferred compensation and nontaxable benefits from this organization, with any from related organizations beside each, and the filer's own total. It is shown with the Part VII listing of the same name on the same return. The form gives no key between the two, so that pairing is ours, and is marked matched by us.
Schedule J
Answered yes
- 3 · Compensation committee
- 3 · Independent compensation consultant
- 3 · Form 990 of other organizations
- 3 · Written employment contract
- 3 · Compensation survey or study
- 3 · Approval by the board or compensation committee
Answered no
- 4a · Severance or change-of-control payment
- 4b · Supplemental nonqualified retirement plan
- 4c · Equity-based compensation arrangement
- 5a · Pay contingent on this organization's revenues
- 5b · Pay contingent on a related organization's revenues
- 6a · Pay contingent on this organization's net earnings
- 6b · Pay contingent on a related organization's net earnings
- 7 · Other non-fixed payments
- 8 · Paid under the initial-contract exception
Part I's answers as filed. A line not listed was left unanswered; on lines 1a and 3 that means the box was not checked.
Grants on this return
-
$343,715
Epidemiology study site
-
Massachusetts General Hospital
$145,963
Epidemiology study site
-
$142,297
Vaccine Acceptance research site
-
Vaccine Acceptance journalist mentoring grant
-
$92,200
Vaccine misinformation intervention module development
-
$77,585
COVID-19 vaccination Community of Practice development
-
AIDS Vaccine Advocacy Coalition
$75,452
Vaccine Acceptance research site
-
Vaccine Acceptance Small Grants Program awardee
-
Vaccine Acceptance Small Grants Program awardee
Provenance
- Return type
- form_990
- Tax year
- 2022
- Filed
- 7 November 2023
- IRS schema version
- 2022v5.0
- Source object
- 202323119349302547
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.